3 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 2 | Terminated 2 |
Follow CRC: new trials by email Literature Review of CRC trials Research Report on CRC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer BMF-219 - Non Small Cell Lung Cancer, Pancreatic Cancer | Phase 1 | Terminated | Biomea Fusion Inc. | 13 | 2023-01-12 | 2025-02-07 |
| Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours OMO-103 - Advanced Solid Tumors, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | Peptomyc S.L. | 22 | 2021-04-28 | 2024-04-25 |
| Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors CB-839, Talazoparib - Solid Tumor, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | Terminated | Calithera Biosciences, Inc | 33 | 2019-05-20 | 2022-02-17 |
Colorectal Neoplasms (2) · Pancreatic Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Recurrence (1) · Triple Negative Breast Neoplasms (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Neoplasms by Site (3) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Pancreatic Diseases (2) · Rectal Diseases (2) · Adenocarcinoma (1) · Breast Diseases (1)
CB-839 (1) · talazoparib (1)
Biomea Fusion Inc. (1) · Calithera Biosciences, Inc (1) · Peptomyc S.L. (1)
United States (2) · South Korea (1) · Spain (1)
Elena Garralda, MD, PhD (1) · Sam Whiting, MD, PhD (1) · Steve Morris, MD (1)